Myoneurogastrointestinal encephalopathy syndrome

Jump to navigation Jump to search

WikiDoc Resources for Myoneurogastrointestinal encephalopathy syndrome

Articles

Most recent articles on Myoneurogastrointestinal encephalopathy syndrome

Most cited articles on Myoneurogastrointestinal encephalopathy syndrome

Review articles on Myoneurogastrointestinal encephalopathy syndrome

Articles on Myoneurogastrointestinal encephalopathy syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Myoneurogastrointestinal encephalopathy syndrome

Images of Myoneurogastrointestinal encephalopathy syndrome

Photos of Myoneurogastrointestinal encephalopathy syndrome

Podcasts & MP3s on Myoneurogastrointestinal encephalopathy syndrome

Videos on Myoneurogastrointestinal encephalopathy syndrome

Evidence Based Medicine

Cochrane Collaboration on Myoneurogastrointestinal encephalopathy syndrome

Bandolier on Myoneurogastrointestinal encephalopathy syndrome

TRIP on Myoneurogastrointestinal encephalopathy syndrome

Clinical Trials

Ongoing Trials on Myoneurogastrointestinal encephalopathy syndrome at Clinical Trials.gov

Trial results on Myoneurogastrointestinal encephalopathy syndrome

Clinical Trials on Myoneurogastrointestinal encephalopathy syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Myoneurogastrointestinal encephalopathy syndrome

NICE Guidance on Myoneurogastrointestinal encephalopathy syndrome

NHS PRODIGY Guidance

FDA on Myoneurogastrointestinal encephalopathy syndrome

CDC on Myoneurogastrointestinal encephalopathy syndrome

Books

Books on Myoneurogastrointestinal encephalopathy syndrome

News

Myoneurogastrointestinal encephalopathy syndrome in the news

Be alerted to news on Myoneurogastrointestinal encephalopathy syndrome

News trends on Myoneurogastrointestinal encephalopathy syndrome

Commentary

Blogs on Myoneurogastrointestinal encephalopathy syndrome

Definitions

Definitions of Myoneurogastrointestinal encephalopathy syndrome

Patient Resources / Community

Patient resources on Myoneurogastrointestinal encephalopathy syndrome

Discussion groups on Myoneurogastrointestinal encephalopathy syndrome

Patient Handouts on Myoneurogastrointestinal encephalopathy syndrome

Directions to Hospitals Treating Myoneurogastrointestinal encephalopathy syndrome

Risk calculators and risk factors for Myoneurogastrointestinal encephalopathy syndrome

Healthcare Provider Resources

Symptoms of Myoneurogastrointestinal encephalopathy syndrome

Causes & Risk Factors for Myoneurogastrointestinal encephalopathy syndrome

Diagnostic studies for Myoneurogastrointestinal encephalopathy syndrome

Treatment of Myoneurogastrointestinal encephalopathy syndrome

Continuing Medical Education (CME)

CME Programs on Myoneurogastrointestinal encephalopathy syndrome

International

Myoneurogastrointestinal encephalopathy syndrome en Espanol

Myoneurogastrointestinal encephalopathy syndrome en Francais

Business

Myoneurogastrointestinal encephalopathy syndrome in the Marketplace

Patents on Myoneurogastrointestinal encephalopathy syndrome

Experimental / Informatics

List of terms related to Myoneurogastrointestinal encephalopathy syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords : mitochondrial neurogastrointestinal encephalopathy disease, MNGIE disease

Overview

Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is a condition that affects several parts of the body, particularly the digestive system and nervous system. The major features of MNGIE disease can appear anytime from infancy to adulthood, but signs and symptoms most often begin by age 20. The medical problems associated with this disorder worsen with time.[1]

Pathophysiology

Genetics

Mutations in the TYMP gene (previously known as ECGF1) cause this disease. This gene provides instructions for making an enzyme called thymidine phosphorylase. Thymidine is a molecule known as a nucleoside, which (after a chemical modification) is used as a building block of DNA. Thymidine phosphorylase breaks down thymidine into smaller molecules, which helps regulate the level of nucleosides in cells.

Epidemiology and Demographics

The prevalence of the disease is unknown. About 70 people with this disorder have been reported.

Diagnosis

History and Symptoms

These gastrointestinal problems lead to extreme weight loss and reduced muscle mass (cachexia).

Physical Examination

Eyes

Neurologic Examination

MRI

Leukoencephalopathy, which is the deterioration of a type of brain tissue known as white matter, is a hallmark of MNGIE disease. These changes in the brain can be seen with magnetic resonance imaging (MRI).

References

Template:WH Template:WS